Corporate raider Melrose bought GKN for £8bn in 2018 in a move that faced fierce opposition over fears the 266-year-old company would be split up and sold off.Read More

You might also be interested in reading Journey Medical GAAP EPS of -$0.18 beats by $0.06, revenue of $13.1M beats by $1.05M.